These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2011569)

  • 21. Culture and antibiotic monitoring service in a community hospital.
    Von Seggern RL
    Am J Hosp Pharm; 1987 Jun; 44(6):1358-62. PubMed ID: 3303924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals.
    Paterson DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S90-5. PubMed ID: 16355322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of antibiotic-resistant bacteria: memorandum from a WHO meeting. World Health Organization Scientific Working Group on Antimicrobial Resistance.
    Am J Hosp Pharm; 1984 Jul; 41(7):1329-37. PubMed ID: 6540519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic restriction in hospitals associated with medical schools.
    Klapp DL; Ramphal R
    Am J Hosp Pharm; 1983 Nov; 40(11):1957-60. PubMed ID: 6650526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assuring rational antibiotic use: the impact of a joint microbiology-pharmacy surveillance program.
    Plumridge RJ; McGechie DB
    Aust Health Rev; 1984; 7(4):269-77. PubMed ID: 10269945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents.
    Hess DA; Mahoney CD; Johnson PN; Corrao WM; Fisher AE
    Am J Hosp Pharm; 1990 Mar; 47(3):585-91. PubMed ID: 2316543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
    Kile DM; McGrath ME; Schindel LP
    Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
    MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW
    J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacy initiatives to reduce clindamycin use.
    Greene SA; Record KE; Rapp RP; Amerson AB; Bell RM; Piecoro JJ
    Am J Hosp Pharm; 1986 May; 43(5):1210-3. PubMed ID: 3717177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the microbiology laboratory in guiding formulary decisions.
    Stratton CW
    Hosp Formul; 1988 Aug; 23(8):654-7. PubMed ID: 10312591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to improve antibiotic use.
    Bryan CS
    Infect Dis Clin North Am; 1989 Dec; 3(4):723-34. PubMed ID: 2687360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial stewardship.
    Rybak MJ
    Pharmacotherapy; 2007 Oct; 27(10 Pt 2):131S-135S. PubMed ID: 17896906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P&T Committee antibiotic cost considerations.
    Rinehart JR
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining the formulary status of quinolone antibiotics: one institution's approach.
    Nightingale CH; Lubowski T; On A; Quintiliani R
    Hosp Formul; 1992 May; 27(5):509-10, 513-4, 516. PubMed ID: 10128710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between formulary strategies and hospital drug expenditures.
    Hazlet TK; Hu TW
    Am J Hosp Pharm; 1992 Sep; 49(9):2207-10. PubMed ID: 1524063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Institution-specific versus published in vitro antimicrobial susceptibility data in making formulary decisions.
    Franson TR; DaMert GJ; Sheth NK; Wisniewski T; Cooper JE; Johnson R; Babcock JB; Hoffmann RG; Malangoni MA
    Am J Hosp Pharm; 1987 Jan; 44(1):95-101. PubMed ID: 3826095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.